ClinicalTrials.gg
TerminatedNCT02509533Updated Jul 28, 2015

Comparison of the Use of VAC System in Transplants of Leg Ulcers Versus Usual Dressing Method

An interventional study of V.A.C.® and dressing in Leg Ulcer, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Terminated at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-07-28.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Not applicable, Interventional, and Treatment

Why this study was terminated
difficulties to recruit patients.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

To evaluate the VAC (Vacuum Assisted Closure) therapy in transplants of leg ulcers versus usual dressing method. The VAC Therapy system consists of:

  • A unit delivering a precise under atmospheric pressure, controlled and regulated in the wound site,
  • Consumables necessary for the implementation of the dressing,
  • Collecting tanks exudates with gel. VAC therapy is a system using negative pressure. It is known to be efficient into care of chronic wounds and ulcerous wounds by increasing the cicatrisation.

This system is systematically used into the dermatology unit of the CHU of Saint-Etienne after transplants of leg ulcers, but no data confirms the interest of this method compared to usual dressing method. This study will provide this data.

02

Conditions studied

  • Leg Ulcer

Browse trials for

Keywords

  • Vacuum Assisted Closure
03

In context

Leg Ulcer

302 studies on the registry are indexed under Leg Ulcer; 43 are open to participants now.

This study's enrollment of 36 is below the median of 60 across 245 interventional studies indexed under Leg Ulcer.

Browse Leg Ulcer studies →

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 597 studies on the registry; 127 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patient hospitalized into the dermatology unit
  • patient with an evolutive leg ulcer since more than 1 month
  • signed informed consent

Exclusion criteria

Exclusion Criteria:

  • known allergy to one of dressings used in this study
  • patient with a non-treated osteomyelitis
  • patient with tumoral tissues into the wound
  • patient with raw organ or raw blood vessels
  • patient with an anticoagulation treatment with a potentially hemorrhagic curative dose
  • patient having hemostasis problems that can lead to hemorrhagic exudates
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    V.A.C.® Therapy

    In this arm, investigators will use the V.A.C.® Therapy after a transplants of leg ulcers.

    Device: V.A.C.®

  • Active comparator
    usual dressing method (compresses)

    In this arm, investigators will use the usual dressing method after a transplants of leg ulcers.

    Device: dressing

Interventions

  • DeviceV.A.C.®

    Patients received V.A.C.® Therapy (KCI medical) after a transplants of leg ulcers.

  • Devicedressing

    Patients received usual dressing method (compresses) after a transplants of leg ulcers

06

What researchers measure

Primary outcomes

  1. Percentage of healing between VAC system and compresses for all types of leg ulcers

    Number of patients having a wound at least 50% of the grafted area between VAC system and compresses

    Time frame: 1 month after the transplant

Secondary outcomes

  1. Percentage of healing between VAC system and compresses for all types of leg ulcers

    Number of patients having a wound at least 50% of the grafted area between VAC system and compresses

    Time frame: 3 months after the transplant

  2. Evolution of the pain by Analogic Visual Scale.

    Pain score as measured by visual analog scale between VAC system and compresses

    Time frame: day 0 : just before the transplant

  3. Evolution of the pain by Analogic Visual Scale.

    Pain score as measured by visual analog scale between VAC system and compresses

    Time frame: day 1 : the day after the transplant

  4. Evolution of the pain by Analogic Visual Scale

    Pain score as measured by visual analog scale between VAC system and compresses

    Time frame: Month 1

  5. Quality of life questionnaire score.

    Quality of life questionnaire score between VAC system and compresses

    Time frame: day 0 : just before the transplant

  6. Quality of life questionnaire score.

    Quality of life questionnaire score between VAC system and compresses

    Time frame: Day 5

  7. Quality of life questionnaire score.

    Quality of life questionnaire score between VAC system and compresses

    Time frame: Month 1

  8. Quality of life questionnaire score.

    Quality of life questionnaire score between VAC system and compresses

    Time frame: Month 3

  9. Cost of the treatment.

    Cost of the treatment, between VAC system and compresses This coast includes costs of consumables, hospitalisation days and nursing costs

    Time frame: Month 3

07

Study locations

1 site
  • CHU de SAINT-ETIENNE
    Saint-Etienne, 42000, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02509533
Responsible party
Sponsor
First posted
Jul 28, 2015
Start date
Sep 2010
Primary completion
Oct 2013
Completion
Mar 2014
Last update
Jul 28, 2015

Study contacts

Bruno LABEILLE, MD
principal investigator · CHU de SAINT-ETIENNE

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion